Corey J Lager1, Nazanene H Esfandiari1, Angela R Subauste2, Andrew T Kraftson1, Morton B Brown3, Ruth B Cassidy4, Darlene Bellers1, Amy L Lockwood1, Oliver A Varban4, Elif A Oral5. 1. Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan Health Systems, Brehm Center for Diabetes, 1000 Wall Street, Room 5313, Ann Arbor, MI, 48105, USA. 2. Division of Endocrinology, University of Mississippi, 2500 N. State St., Jackson, MS, 39216, USA. 3. Department of Biostatistics, School of Public Health, University of Michigan, M4039 SPH II, 1415 Washington Heights, Ann Arbor, MI, 48109, USA. 4. Division of Minimally Invasive Surgery, Department of General Surgery, University of Michigan, 1500 E Medical Center Dr SPC 5343, Ann Arbor, MI, 48109, USA. 5. Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan Health Systems, Brehm Center for Diabetes, 1000 Wall Street, Room 5313, Ann Arbor, MI, 48105, USA. eliforal@med.umich.edu.
Abstract
BACKGROUND: Rates of weight normalization and obesity remission after Roux-en-Y gastric bypass (GB) are unknown. This study evaluated weight loss, rates of achieving body mass index (BMI) <25 or 30 kg/m2, recidivism, and predictors of success following GB. METHODS: We retrospectively studied weight and BMI at baseline, 2 and 6 months, and annually at 1-7 years in 219 patients undergoing GB at the University of Michigan from January 2008 to November 2010. RESULTS: Follow-up was excellent for a population traditionally associated with high attrition rates with data availability of 157/219, 145/219, 144/219, 134/219, 123/219, 82/161, and 29/64 patients at 1-7 years, respectively. Mean baseline BMI was 47.0 kg/m2. Weight normalization (BMI <25 kg/m2) occurred in 2.3-6.8% of patients. More importantly, 47% of patients achieved remission of obesity (BMI <30 kg/m2) at some time point and 24% (52/219) at the last observed time point. BMI <30 kg/m2 was associated with a lower initial BMI and follow-up for more than 2 years. CONCLUSIONS: Rates of weight normalization are low after GB; however, a large number of patients achieved BMI <30 kg/m2. While the percent total weight loss and excess weight loss are both quite high in the entire cohort and this is likely associated with significant health benefits, our results still underscore the need to address obesity with intensive clinical attention earlier in its course.
BACKGROUND: Rates of weight normalization and obesity remission after Roux-en-Y gastric bypass (GB) are unknown. This study evaluated weight loss, rates of achieving body mass index (BMI) <25 or 30 kg/m2, recidivism, and predictors of success following GB. METHODS: We retrospectively studied weight and BMI at baseline, 2 and 6 months, and annually at 1-7 years in 219 patients undergoing GB at the University of Michigan from January 2008 to November 2010. RESULTS: Follow-up was excellent for a population traditionally associated with high attrition rates with data availability of 157/219, 145/219, 144/219, 134/219, 123/219, 82/161, and 29/64 patients at 1-7 years, respectively. Mean baseline BMI was 47.0 kg/m2. Weight normalization (BMI <25 kg/m2) occurred in 2.3-6.8% of patients. More importantly, 47% of patients achieved remission of obesity (BMI <30 kg/m2) at some time point and 24% (52/219) at the last observed time point. BMI <30 kg/m2 was associated with a lower initial BMI and follow-up for more than 2 years. CONCLUSIONS: Rates of weight normalization are low after GB; however, a large number of patients achieved BMI <30 kg/m2. While the percent total weight loss and excess weight loss are both quite high in the entire cohort and this is likely associated with significant health benefits, our results still underscore the need to address obesity with intensive clinical attention earlier in its course.
Authors: Jonathan F Finks; Kerry L Kole; Panduranga R Yenumula; Wayne J English; Kevin R Krause; Arthur M Carlin; Jeffrey A Genaw; Mousumi Banerjee; John D Birkmeyer; Nancy J Birkmeyer Journal: Ann Surg Date: 2011-10 Impact factor: 12.969
Authors: Alison Fildes; Judith Charlton; Caroline Rudisill; Peter Littlejohns; A Toby Prevost; Martin C Gulliford Journal: Am J Public Health Date: 2015-07-16 Impact factor: 9.308
Authors: Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap Journal: N Engl J Med Date: 2014-03-31 Impact factor: 91.245
Authors: Joel Faintuch; Mitsunori Matsuda; Maria Emilia L F Cruz; Marlene M Silva; Marcelo P Teivelis; Arthur B Garrido; J J Gama-Rodrigues Journal: Obes Surg Date: 2004-02 Impact factor: 4.129
Authors: Noah J Switzer; Shaheed Merani; Daniel Skubleny; Jean-Sébastien Pelletier; Raisa Kanji; Xinzhe Shi; Daniel W Birch; Christopher de Gara; Arya M Sharma; Richdeep S Gill; Shahzeer Karmali Journal: Ann Surg Date: 2016-05 Impact factor: 12.969
Authors: Corey J Lager; Nazanene H Esfandiari; Angela R Subauste; Andrew T Kraftson; Morton B Brown; Ruth B Cassidy; Catherine K Nay; Amy L Lockwood; Oliver A Varban; Elif A Oral Journal: Obes Surg Date: 2017-01 Impact factor: 4.129
Authors: Michael Messerli; Céline Maywald; Stephan Wälti; René Warschkow; Simon Wildermuth; Hatem Alkadhi; Sebastian Leschka; Marc Schiesser Journal: Obes Surg Date: 2017-08 Impact factor: 4.129
Authors: Brandon T Grover; Michael C Morell; Shanu N Kothari; Andrew J Borgert; Kara J Kallies; Matthew T Baker Journal: Obes Surg Date: 2019-11 Impact factor: 4.129
Authors: Tone Nygaard Flølo; Grethe S Tell; Ronette L Kolotkin; Anny Aasprang; Tone Merete Norekvål; Villy Våge; Karl Ove Hufthammer; John Roger Andersen Journal: BMJ Open Date: 2019-09-12 Impact factor: 2.692